We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Kymera Therapeutics
KYMR
$8.99B
| – | – |
-21
| Closed | -$1K | – |
|
3127
Liberty Global Class A
LBTYA
$2.74B
| $0 | ﹤0.01% |
10
-14
| -58% | -$371 |
2021 Q3
2 quarters
|
|
3128
Liberty Global Class C
LBTYK
$2.69B
| $0 | ﹤0.01% |
8
+2
| +33% | +$53 |
2020 Q4
5 quarters
|
|
3129
Happen Inc
HAPN
$1.69B
| $0 | ﹤0.01% |
+6
| New | +$111 |
2022 Q1
0 quarters
|
|
3130
Lifetime Brands
LCUT
$202M
| – | – |
-71
| Closed | -$1K | – |
|
3131
Lands' End
LE
$304M
| $0 | ﹤0.01% |
+15
| New | +$268 |
2022 Q1
0 quarters
|
|
3132
LGI Homes
LGIH
$1.02B
| $0 | ﹤0.01% |
1
-14
| -93% | -$1.73K |
2021 Q3
2 quarters
|
|
3133
Ligand Pharmaceuticals
LGND
$5.95B
| – | – |
-5
| Closed | – | – |
|
3134
Liberty Latin America Class A
LILA
$1.62B
| $0 | ﹤0.01% |
29
-479
| -94% | -$3.45K |
2021 Q4
1 quarter
|
|
3135
LKQ Corp
LKQ
$5.66B
| – | – |
-1,307
| Closed | -$78K | – |
|
3136
Lindsay Corp
LNN
$1.12B
| – | – |
-32
| Closed | -$5K | – |
|
3137
Lantheus
LNTH
$6.53B
| $0 | ﹤0.01% |
8
-64
| -89% | -$2.4K |
2021 Q4
1 quarter
|
|
3138
Live Oak Bancshares
LOB
$1.63B
| $0 | ﹤0.01% |
+4
| New | +$256 |
2022 Q1
0 quarters
|
|
3139
El Pollo Loco
LOCO
$497M
| $0 | ﹤0.01% |
26
-21
| -45% | -$271 |
2021 Q1
4 quarters
|
|
3140
Loop Industries
LOOP
$18M
| $0 | ﹤0.01% |
50
| – | – |
2018 Q3
14 quarters
|
|
3141
Lightspeed Commerce
LSPD
$1.41B
| $0 | ﹤0.01% |
3
+2
| +200% | +$60 |
2020 Q4
5 quarters
|
|
3142
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.09B
| $0 | ﹤0.01% |
1
| – | – |
2020 Q4
5 quarters
|
|
3143
LXP Industrial Trust
LXP
$3.6B
| – | – |
-23
| Closed | -$2K | – |
|
3144
Merchants Bancorp
MBIN
$2.25B
| – | – |
-182
| Closed | -$6K | – |
|
3145
MasterCraft Boat Holdings
MCFT
$485M
| $0 | ﹤0.01% |
+4
| New | +$106 |
2022 Q1
0 quarters
|
|
3146
Marcus Corp
MCS
$883M
| $0 | ﹤0.01% |
27
-74
| -73% | -$1.3K |
2021 Q3
2 quarters
|
|
3147
Madrigal Pharmaceuticals
MDGL
$10.6B
| $0 | ﹤0.01% |
+3
| New | +$253 |
2022 Q1
0 quarters
|
|
3148
Ramaco Resources Class A
METC
$531M
| – | – |
-518
| Closed | -$7K | – |
|
3149
Roundhill Metaverse ETF
METV
$234M
| – | – |
-100
| Closed | -$2K | – |
|
3150
MidCap Financial Investment
MFIC
$700M
| $0 | ﹤0.01% |
9
| – | – |
2021 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.